Alice Zheng is a Principal at RH Capital, a venture fund investing in early-stage high-impact companies across the reproductive and maternal health landscape.

Alice holds an MBA from Harvard Business School and MD and MPH from the University of Michigan. Alice was previously a women’s health practice leader at McKinsey & company. In this episode of lab to startup, we talk about femtech and women’s health which is gathering some momentum of late; investment thesis of RH Capital and ways they work with founders; opportunities and challenges in this space; and also try to cover some topics that can help encourage aspiring female founders and investors not yet in this space. Shownotes: - https://rhiaventures.org/rhcapital/ - RH Capital, a Rhia Ventures fund, invests in early-stage high-impact companies that are driving innovation, access, and equity across the reproductive and maternal health landscape - Femtech/Women's health - Huge white spaces for investments into women's health - Networking for aspiring female founders - How other VCs can invest in this space - Making a business case for women's health - Areas ripe for investments - Roe v Wade: How innovation ecosystem can help the consequences - Hot off the press article written by Alice in HBS healthcare blog: https://www.hbs.edu/healthcare/blog/post/doubling-down-on-womens-health-innovation-and-leveraging-the-private-sector-in-a-post-roe-v-wade-era -- A few articles Alice co-authored while at McKinsey on women's health needs and innovation trends: https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/the-dawn-of-the-femtech-revolution https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/unlocking-opportunities-in-womens-healthcare